Successful use of venovenous extracorporeal membrane oxygenation for complicated H1N1 pneumonia refractory to mechanical ventilation

Journal of Extra-Corporeal Technology

Volumn 43, Issue 2, 2011, Pages 70-74

  Patel, Sachit A ^a   DeMare, Jeffrey S ^a,b   Truemper, Edward J ^a,b   Deptula, Joseph J ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b CHILDREN S HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Acute respiratory distress; Extracorporeal membrane oxygenation; H1N1; Hypoxia; Influenza; Methicillin resistant staphylococcus aureus

Indexed keywords

ADRENALIN; ALBUMIN; AZITHROMYCIN; CATECHOLAMINE; CEFTRIAXONE; DOCARPAMINE; LACTIC ACID; OSELTAMIVIR; SODIUM CHLORIDE; VANCOMYCIN; VASOPRESSIN;

ABNORMAL RESPIRATORY SOUND; ADULT; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL PNEUMONIA; BLOOD GAS ANALYSIS; BRONCHOPNEUMONIA; BRONCHOSCOPY; CASE REPORT; CHILD; COMORBIDITY; DRUG WITHDRAWAL; EXTRACORPOREAL OXYGENATION; FATIGUE; FEMALE; FEVER; GRAM POSITIVE COCCI; HEADACHE; HUMAN; HYPOTENSION; INFLUENZA A (H1N1); INFLUENZA VACCINATION; INFLUENZA VIRUS A; INTUBATION; LACTATE BLOOD LEVEL; LUNG COMPLIANCE; LUNG DISEASE; LUNG LAVAGE; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBID OBESITY; NEUTROPHIL; OXYGEN MASK; POSITIVE END EXPIRATORY PRESSURE; RESPIRATORY DISTRESS; RESPIRATORY FAILURE; SCHOOL CHILD; TACHYCARDIA; THORAX RADIOGRAPHY; URINE VOLUME; VOMITING;

EID: 79961226568     PISSN: 00221058     EISSN: 29698960     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Centers for Disease Control and Prevention (CDC). Update: Novel influenza A (H1N1) virus infection - Mexico. March-May 2009. MMWR Morb Mortal Wkly Rep. 2009;58:585-9.
2. Lister P, Reynolds F, Parslow R, et al. Swine-origin influenza virus H1N1, seasonal influenza virus, and critical illness in children. Lancet. 2009;374:605-7.
3. Thompson WW, Shay DK, Weintraub E, et al. Influenza-associated hospitalizations in the United States. JAMA. 2004;292:1333-40.
4. Freed DH, Henzler D, White CW, et al. Extracorporeal lung support for patients who had severe respiratory failure secondary to influenza A (H1N1) 2009 infection in Canada. Can J Anaesth. 2010;57:240-7.
5. Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators, Davies A, Jones D, Bailey M, et al. Extracorporeal membrane oxygenation for 2009 influenza A (H1N1) acute respiratory distress syndrome. JAMA. 2009;302:1888-95.
6. Helferty M, Vachon J, Tarasuk J, et al. Incidence of hospital admissions and severe outcomes during the first and second waves of pandemic (H1N1) 2009. CMAJ. 2010;182:1981-7.
7. Mitchell MD, Mikkelsen ME, Umscheid CA, et al. A systematic review to inform institutional decisions about the use of extracorporeal membrane oxygenation during the H1N1 influenza pandemic. Crit Care Med. 2010;38:1398-404.
8. ECMO registry of the extracorporeal life support organization (ELSO), Ann Arbor, Michigan. Available at: http://www.elso.med.umich.edu. Accessed July 1, 2010.
9. Marasco SF, Lukas G, McDonald M, et al. Review of ECMO (extra corporeal membrane oxygenation) support in critically ill adult patients. Heart Lung Circ. 2008;17(Suppl 4):S41-7.
10. Keckler SJ, Laituri CA, Ostlie DJ, St Peter SD. A review of venovenous and venoarterial extracorporeal membrane oxygenation in neonates and children. Eur J Pediatr Surg. 2010;20:1-4.
11. Pettignano R, Fortenberry JD, Heard ML, et al. Primary use of the venovenous approach for extracorporeal membrane oxygenation in pediatric acute respiratory failure. Pediatr Crit Care Med. 2003;4:291-8.
12. Brogan TV, Thiagarajan RR, Rycus PT, et al. Extracorporeal membrane oxygenation in adults with severe adult respiratory failure. A multicenter database. Intensive Care Med. 2009;35:2105-14.
13. Pranikoff T, Hirschl RB, Steinle CN, et al. Mortality is directly related to the duration of mechanical ventilation before the initiation of extracorporeal life support for severe respiratory failure. Crit Care Med. 1997;25:28-32.
14. Peek GJ, Mugford M, Tiruvoipati R, et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure: A multicenter randomized controlled trial. Lancet. 2009;374:1351-63.
15. Lapinsky SE. H1N1 novel influenza A in pregnant and immunocompromised patients. Crit Care Med. 2010;38:e52-7.
16. Hewagama S, Walker SP, Stuart RL, et al. 2009 H1N1 influenza A and pregnancy outcomes in Victoria, Australia. Clin Infect Dis. 2010;50:686-90.
17. Vaillant L, La Ruche G, Tarantola A, Barboza P. Epidemiology of fatal cases associated with pandemic H1N1 influenza 2009. Euro Surveill. 2009;14:1-6.
18. Palacios G, Hornig M, Cisterna D, et al. Streptococcus pneumoniae coinfection is correlated with the severity of H1N1 pandemic influenza. PLoS ONE. 2009;4:e8540.
19. Reed C, Kallen AJ, Patton M, et al. Infection with community-onset staphylococcus aureus and influenza virus in hospitalized children. Pediatr Infect Dis J. 2009;28:572-6.
20. Morens DM, Taubenberger JK, Fauci AS. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: Implications for pandemic influenza preparedness. J Infect Dis. 2008;198:962-70.
21. Shun-Shin M, Thompson M, Heneghan C, et al. Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: Systematic review and meta-analysis of randomized controlled trials. BMJ. 2009;339:1-9.
22. Goldstein E, Cowling BJ, O'Hagan JJ, et al. Oseltamivir for treatment and prevention of pandemic influenza A/H1N1 virus infection in households, Milwaukee, 2009. BMC Infect Dis. 2010;10:211-7.